AVAI (Avai Bio) Forward PE Ratio: 0.00 (As of Jun. 30, 2026)


AVAI Avai Bio Inc AVAI
24 GF Score
Price $0.16
! 3 Warning Signs
View Full Analysis

What is Avai Bio Forward PE Ratio?

Avai Bio AVAI +3.45% 24 Forward PE Ratio is 0.00 as of Jun. 30, 2026. GuruFocus rates AVAI with a GF Score™ of 24/100. The stock has 3 warning signs investors should review. Among 1,169 Software companies, Avai Bio ranks worse than 85543.11% on this metric.

Avai Bio's Forward PE Ratio for today is 0.00.

Avai Bio's PE Ratio without NRI for today is 9999.00.

Avai Bio's PE Ratio (TTM) for today is 9999.00.


Avai Bio  (OTCPK:AVAI) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Avai Bio Forward PE Ratio Related Terms


Avai Bio Forward PE Ratio Historical Data

* Premium members only.

The historical data trend for Avai Bio's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avai Bio Forward PE Ratio Chart

Avai Bio Annual Data
Trend
Forward PE Ratio

Avai Bio Quarterly Data
Forward PE Ratio

AVAI vs IPM, RCT, LPSN: Forward PE Ratio Comparison

For the Software - Application subindustry, Avai Bio's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avai Bio Forward PE Ratio vs Software Industry

For the Software industry and Technology sector, Avai Bio's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Avai Bio's Forward PE Ratio falls into.


AVAI
24GF Score
Avai Bio Inc AVAI
Forward PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avai Bio Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Frequently Asked Questions Learn more about Forward PE Ratio →
What does a Forward PE Ratio of 0.00 mean?
Avai Bio (AVAI) has a Forward PE Ratio of 0.00 as of Jun. 30, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Avai Bio and its competitors. According to the industry distribution chart, Avai Bio ranks #999999 out of 1169 companies in the Software industry.
Is Avai Bio's Forward PE Ratio too high?
Avai Bio's current Forward PE Ratio is 0.00. Based on the distribution chart, Avai Bio ranks #999999 out of 1169 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Avai Bio has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Avai Bio's Forward PE Ratio compare to IPM and RCT?
According to the Software industry distribution chart, Avai Bio ranks #999999 out of 1169 companies for Forward PE Ratio. This places Avai Bio in the lower half of its industry. The industry median Forward PE Ratio is 17.79. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Software company?
The median Forward PE Ratio among Software companies is 17.79, based on 1,169 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Avai Bio and its competitors. For the Software industry, the median Forward PE Ratio is 17.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avai Bio's current Forward PE Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avai Bio stock overvalued right now?
Avai Bio (AVAI) has a current Forward PE Ratio of 0.00. The current Forward PE Ratio is 0.00. Avai Bio's overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Avai Bio (AVAI), the current Forward PE Ratio is 0.00 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avai Bio Business Description

Address 5348 Vegas Drive, Las Vegas, NV, USA, 89108
Avai Bio Inc is a biotechnology company focused on identifying genetically modified cell lines, and through joint venture and licensing agreements, developing cell-based therapies. The company has two development programs in its cellular therapies pipeline, a diabetes development program to advance a treatment for type 1 and type 2 insulin-dependent diabetes, and an ?-Klotho protein development program to advance therapies for age-related diseases and anti-aging treatments.
24GF Score

Get the complete analysis for AVAI

Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.16
Price